SPAC
What to Watch as DRC Medicine's SPAC Merger Heads to Close
DRC Medicine, a Japan-based healthcare and biotech company focused on therapeutic masks and AI-enabled diagnostics, is going public through a merger with Ribbon Acquisition Corp. (Nasdaq: RIBB). The deal is already effective and in the closing stage, but the key question is how much trust cash survives redemptions and how much dilution comes with the financing stack.
Sep 4, 20266 MIN
